Tag: hydrocephalus

Anuncia announces publication of “promising” hydrocephalus outcomes with ReFlow ventricular system

Anuncia Medical has announced that an article highlighting its US Food and Drug Administration (FDA)-cleared and CE-marked ReFlow ventricular system (Gen 1) with hydrocephalus...

Rhaeos raises US$10.5 million in Series A funding to boost hydrocephalus...

Rhaeos has announced the successful closing of US$10.5 million in Series A funding, led by the Steele Foundation for Hope, bringing the company’s total funding to more...

Pedro Lylyk

Pedro Lylyk’s work and achievements in the neurosurgical field have spanned several decades, and range from a momentous intracranial stent placement in 1996, to...

CereVasc receives FDA nod to study eShunt system in normal-pressure hydrocephalus...

CereVasc has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application to initiate a pilot trial...

CereVasc announces publication of first-in-human case report with eShunt system

CereVasc has announced the publication of a case report detailing the first treatment in a study of its eShunt system—an investigational device intended to...

Rhaeos awarded US$4 million NIH grant to expand sensor technology for...

Rhaeos has been awarded a US$4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) programme through the...
qure.ai

Qure.ai lands second FDA clearance for AI-based brain scan technology

Qure.ai has announced US Food and Drug Administration (FDA) 510(k) clearance for its brain computed tomography (CT) quantification product qER-Quant. Clinicians in the USA...

First patient treated in eShunt clinical trial 

CereVasc has announced the treatment of the first patient in a study of its eShunt System, an investigational device intended to treat communicating hydrocephalus...